PathAI AISight
by PathAI
A cloud-based digital pathology image management system from PathAI for viewing, managing, and sharing whole-slide images and associated case data, with support for research workflows and AI applications.
Why Abandoned
PathAI currently maintains an AISight product page and announced AISight DX as FDA-cleared for primary diagnosis in the United States in 2023. No verified shutdown or acquisition of the product was found.
🩺 Health Signals
- HTTP Status
- 200
- Response
- —
- SSL
- —
- Confidence
- 91%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
AISight launched
PathAI introduced AISight as a cloud-based digital pathology platform designed to support slide viewing, image management, collaboration, and AI-powered pathology workflows.
PathAI acquired Poplar Healthcare
PathAI acquired Poplar Healthcare, a pathology laboratory services company, expanding its clinical diagnostics operations and access to pathology workflow expertise.
AISight received CE marking
PathAI announced CE marking for AISight as a medical device for primary diagnosis in the European Economic Area.
AISight DX received FDA clearance
PathAI announced FDA 510(k) clearance for AISight DX as a digital pathology image management system for primary diagnosis in the United States.
🔄 Alternatives to PathAI AISight
Bard / Gemini
🟢ActiveGoogle's AI assistant, originally Bard, rebranded to Gemini with multimodal capabilities.
Hugging Face
🟢ActiveThe GitHub of machine learning — hosting models, datasets, and AI applications.
OpenAI API
🟢ActiveAPI platform providing access to GPT models for developers to build AI applications.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is PathAI AISight?
PathAI AISight is a cloud-based digital pathology platform used to view, organize, manage, and share digitized pathology slides and related case information.
What is PathAI AISight used for?
Pathology laboratories and research teams use AISight for whole-slide image review, case collaboration, image and data management, and access to compatible computational pathology applications.
Is PathAI AISight FDA cleared?
PathAI announced in September 2023 that AISight DX received FDA 510(k) clearance as a digital pathology image management system for primary diagnosis in the United States.
Can PathAI AISight be used for primary diagnosis?
The regulated AISight DX configuration is cleared in the United States for primary diagnosis when used according to its FDA-cleared indications, supported scanners, displays, and labeling. Availability and permitted use can vary by jurisdiction.
Who owns and develops PathAI AISight?
AISight is developed and offered by PathAI, a Boston-based company founded by Andy Beck and Aditya Khosla that builds AI and digital pathology products for biopharma and diagnostic laboratories.